MedTrace Logo

The StoneBreakerTM Trial

NCT00677196 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2010-09-27

No results posted yet for this study

Summary

The purpose of this study is to compare the LMA StoneBreakerTM to the current standard of pneumatic lithotripsy, the Swiss LithoClastR, during percutaneous nephrolithotripsy (PNL).

Conditions

  • Percutaneous Nephrolithotripsy

Interventions

DEVICE

The stonebreaker arm (LMA Stonebreaker)

The interventional device name is the LMA Stonebreaker pneumatic handheld lithotriptor.

DEVICE

Pneumatic Lithotripsy (Swiss LithoClastR)

Pneumatic lithotripsy, the Swiss LithoClastR during percutaneous nephrolithotripsy (PNL)

Sponsors & Collaborators

  • VGH and UBC Hospital Foundation

    collaborator OTHER

  • Vancouver Coastal Health

    collaborator OTHER_GOV

  • University of British Columbia

    lead OTHER

Principal Investigators

  • Ben Chew, MD, FRCSC · University of British Columbia

  • R. Paterson, MD · University of British Columbia

  • J. Wright, MD · University of British Columbia

  • J. Teichman, MD · University of British Columbia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-02-29
Primary Completion
2010-09-30
Completion
2010-09-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00677196 on ClinicalTrials.gov